← All trials
NCT01365559
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 2, 2011
- Primary completion
- Jun 13, 2014
- Completion date
- Mar 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 45
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- OncotherapeuticsLead sponsor
- James R. Berenson MD, Inc.Overall official - principal investigator
- AmgenCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.